Small molecule glucagon receptor antagonists: an updated patent review (2015

Small molecule glucagon receptor antagonists: an updated patent review (2015–2019)

Published:2020-06-18 Issue:7 Volume:30 Page:509-526
ISSN:1354-3776
Container-title:Expert Opinion on Therapeutic Patents
language:en
Short-container-title:Expert Opinion on Therapeutic Patents

Author:

Cheng Chen¹^ORCID,Jabri Salman¹,Taoka Brandon M¹,Sinz Christopher J¹²

Affiliation:

1. Merck & Co., Inc, South San Francisco, California, USA (MSD)

2. Current Address: Maze Therapeutics, South San Francisco, California, USA

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543776.2020.1769600

Reference97 articles.

1. Diabetes [Internet]. 2017 [cited 2018 Sep 17]. Available from: http://www.who.int/news-room/fact-sheets/detail/diabetes.

2. 2017 diabetes report card [Internet]. 2017 [cited 2018 Sep 17]. Available from: https://www.cdc.gov/diabetes/pdfs/library/diabetesreportcard2017-508.pdf.

3. National Diabetes Statistics Report, 2017 [Internet]. 2017 [cited 2018 Sep 17]. Available from: http://www.diabetes.org/assets/pdfs/basics/cdc-statistics-report-2017.pdf.

4. 1. Improving Care and Promoting Health in Populations: Standards of Medical Care in Diabetes—2019

5. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Inferential Binding Sites of GCGR for Small Molecules Using Protein Dynamic Conformations and Crystal Structures;International Journal of Molecular Sciences;2024-08-01

2. Investigational and emerging gastric inhibitory polypeptide (GIP) receptor-based therapies for the treatment of obesity;Expert Opinion on Investigational Drugs;2024-07-17

3. Liraglutide innovations: a comprehensive review of patents (2014–2024);Pharmaceutical Patent Analyst;2024-07-16

4. Hepatic glucagon action: beyond glucose mobilization;Physiological Reviews;2024-07-01

5. Mechanisms of Glucagon Receptor Agonism and GLP-1/Glucagon/GIP Receptor Triple Agonism for Treatment of Diabetes and Obesity;The Journal of Korean Diabetes;2024-06-30